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Abstract
This study aimed at assessing the performance of three external risk-adjusted models – logistic EuroSCORE, Parsonnet score and Ontario
Province Risk (OPR) score – in predicting in-hospital mortality in patients submitted to coronary artery bypass graft (CABG) and to develop
a local risk-score model. Data on 4567 patients who underwent isolated CABG (1992–2001) were extracted from our clinical database.
Hospital mortality was 0.96% (44 patients). For the three external systems, observed and predicted mortalities were compared, and
discrimination and calibration were assessed. A local risk model was developed and validated by means of logistic regression and bootstrap
analysis. The EuroSCORE predicted a mortality of 2.34% (P-0.001 vs. observed), the Parsonnet 4.43% (P-0.0001) and the OPR 1.66%
(P-0.005). All models overestimated mortality significantly in almost all tertile risk groups. The areas under the ROC curve (AUC) for
EuroSCORE, Parsonnet and OPR were 0.754, 0.664 and 0.683, respectively. The local model exhibited good calibration and discrimination
AUC, 0.752. In conclusion, the three risk-score systems analyzed do not accurately predict in-hospital mortality in our coronary surgery
patients; hence their use for risk prediction may not be appropriate in our population. We developed a risk-prediction model that can be
used as an instrument to provide accurate information about the risk of in-hospital mortality in our patient population.
 2007 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Decision-making, preoperative patient education and con-
sent, and quality control are some important areas where
risk prediction models play an important role in current
cardiac surgical practice w1x. These targets require scoring
systems with good performance on three aspects: discrimi-
nation, calibration and stability over a wide spectrum of
risk.
We had previously sensed that the most commonly used
risk-score systems did not accurately predict mortality in
our patient population, but had yet not been able to
analyze and quantify the discrepancy. Hence, our purpose
was first, to assess the performance of three risk-adjusted
predictive models – the EuroSCORE w2x, the Parsonnet score
w3x and the Ontario Province Risk score w4x – in predicting
in-hospital mortality in our patients submitted to CABG.
Secondly, to develop and validate a risk model for in-
hospital mortality with the aim to provide information to
clinicians and patients about the risk in our patient popu-
lation anticipating CABG.
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Society of Thoracic Surgeons, Stockholm, Sweden, September 10–13, 2006.
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2. Materials and methods
2.1. Data
The present study includes 4567 patients submitted to
isolated CABG at our institution in a 10-year period, from
January 1992 through December 2001. Pre-operative, oper-
ative and in-hospital outcome data were prospectively
collected.
There were 4030 men (88.2%) and 537 women and the
mean age was 60.6"9.2 years. All operations were per-
formed under hypothermic ventricular fibrillation, without
cardioplegia, or empty beating heart, a technique
described in detail in previous reports w5, 6x. The mean
number of grafts per patient was 2.8"0.8 and mean
cardiopulmonary bypass time was 63.3"22.9 min. The end-
point of the study was in-hospital mortality, defined as
death during hospital stay, unlimited in time. All survivors
were discharged to their home. The overall observed in-
hospital mortality was 44 patients (0.96%). The interval
between surgery and death ranged from 1 to 127 days, and
six deaths (13.6%) occurred beyond 30 days.
2.2. Analysis
2.2.1. Performance of external risk models
Three risk scores were calculated retrospectively: the
logistic EuroSCORE, the Parsonnet score and the Ontario
Province Risk (OPR) score w2–4x.
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Definitions of four of the risk factors in our database
differed from those of the EuroSCORE. However, some
adjustments or approximate assumptions were made to
enable the analysis (Table 1), a methodology previously
used by others w7, 8x. We did not have data on pulmonary
hypertension and critical pre-operative state, hence the
effect of these risk factors was not incorporated into the
calculation. We obtained a good definition match between
our variables and the Parsonnet and OPR risk factors but,
as suggested by others w9x, we did not use the subjective
risk factors catastrophic states and other rare circumstanc-
es that were included in the original Parsonnet model.
A logistic regression analysis of in-hospital mortality
on the resulting scores was performed, which enabled the
measurement of both the discrimination and the calibration
of each of these scores on our population. Performance
of the models was also assessed by comparing the observed
and expected mortality in tertiles of risk. The percent
difference between the predicted and observed hospital
mortality was calculated using the following formula: w(pre-
dicted deaths)y(observed deaths)x=100y(predicted
deaths). The Fisher exact test was used for the contingency
tables.
2.2.2. Local risk prediction model for in-hospital mortality
More than 50 pre-operative patient variables were avail-
able from the database, of which 21 potential risk factors
were chosen, identified from clinical knowledge and pre-
vious research w10x (Appendix A). The entire database was
initially used to develop the predictive logistic model.
Survivors and non-survivors were initially compared by
univariate analysis performed with the unpaired Student-
t-test or the Mann–Whitney test for numeric variables, and
the x test or the Fisher exact test for categorical variables.2
Variables with a P-0.2 at univariate analysis were used as
independent variables in a forward stepwise logistic regres-
sion analysis with in-hospital mortality as the binary
dependent variable. Because of the relatively small effec-
tive sample size (44 deaths), a P-0.1 was selected for
variable retention in the final regression model. A bootstrap
analysis was used in combination with the logistic regression
analysis to select the final set of risk factors included in
the model. In the bootstrap procedure, 200 samples of
4567 patients were sampled with replacement. A stepwise
logistic regression analysis was applied to every bootstrap
sample. If the predictors occurred in more than 50% of the
bootstrap models, they were judged to be reliable and
were retained in the final model. Unreliable variables, if
present, were removed from the final model.
Finally, we internally validated the risk-prediction model
by randomly drawing 200 samples each containing 100% of
the total number of subjects. The risk-prediction model
was applied to each sample to calculate an individual
sample area under the ROC curve (AUC) and then the mean
and standard error of the mean with 95% confidence
intervals (95% CI) for all 200 ROC values.
Two different properties were used to evaluate the pre-
dictive accuracy of the model: calibration and discrimina-
tion. Calibration was evaluated by the Hosmer–Lemeshow
goodness-of-fit method. A statistically non-significant result
(P)0.05) suggests that the model predicts accurately on
average. In order to get more insight into the model
performance across the ranges of patient deciles of risk,
we plotted the observed and expected mortality in these
risk groups. Discrimination was evaluated by analysis of the
AUC. If the area is greater than 0.7, it can be concluded
that the model has an acceptable discriminatory power
w11x and, consequently, may be used to rank patients into
treatment groups to facilitate management.
3. Results
3.1. Performance of the external risk scores in our
population
The 44 deaths observed, resulted in an overall observed
mortality rate of 0.96%. The logistic EuroSCORE predicted
a mortality rate of 2.34% (P-0.001 vs. observed), the
Parsonnet score 4.42% (P-0.0001 vs. observed) and the
OPR score 1.66% (P-0.005 vs. observed). The percent
difference between the predicted and observed in-hospital
mortality was 58.9% for EuroSCORE (P-0.001), 78.8% for
Parsonnet (P-0.0001) and 42.1% for OPR (Ps0.005). The
exploration of the models at tertiles of risk showed that
all three models overestimated mortality significantly in
each risk group, except the OPR in the first tertile (Table
2). The Hosmer–Lemeshow test for the three models
returned statistically significant results (P-0.01). These
results suggest that these risk models do not predict in-
hospital mortality accurately and, consequently, their use
for risk prediction may not be appropriate in our patient
population.
The AUC for the EuroSCORE was 0.754 (95% CI, 0.679–
0.828), suggesting that the EuroSCORE may be used in our
population only to stratify patients into risk groups. The
use of the other two scoring systems is less appropriate, as
the AUC for the Parsonnet and the OPR were 0.664 (95%
CI, 0.584–0.744) and 0.683 (95% CI, 0.616–0.749),
respectively.
3.2. Local risk prediction model for in-hospital mortality
Table 3 summarizes the variables used in the model and
their frequency of occurrence (%) in bootstrap analyses,
regression coefficients, odds ratio and associated P-values.
Model predictors of in-hospital mortality included: age
(increasing), reoperation, peripheral vascular disease, left
ventricular dysfunction (EF-40%) and non-elective surgery.
All these risk factors occurred in more than 50% of the
bootstrap samples, indicating reliability.
The regression model derived significantly predicted the
occurrence of in-hospital mortality in this data set wx (52
d.f.) s48.45, P-0.001x. The correlation between the
observed and expected number of deaths was high
(rs0.99). The Hosmer–Lemeshow goodness-of-fit test was
not statistically significant (Ps0.979) and the observed
proportion of deaths in each decile risk group tended to
conform with the average predicted probability of death in
that risk group (Fig. 1). These results indicate that the
model accurately predicts in-hospital mortality, both on
average and across the ranges of patient deciles of risk
and, hence, is suitable for use in all (low to high-risk)
patients.
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Table 1
Definitions of risk factors in EuroSCORE and local database
Risk factor EuroSCORE definition Local definition match
Chronic pulmonary Long-term use of Patient requires pharmacologic
disease bronchodilators or steroids for therapy for the treatment of chronic
lung disease pulmonary compromise, or patient
has a FEV -75% of predicted value1
Extra-cardiac Any one or more of the Patient has peripheral vascular
arteriopathy following: claudication, carotid disease as indicated by claudication
occlusion or )50% stenosis, either with exertion or at rest;
previous or planned amputation for arterial insufficiency;
intervention on limb arteries or carotids aorto-iliac occlusive disease
reconstruction; peripheral vascular
bypass surgery, angioplasty or stent;
documented AAA, AAA repair, or
stent; or non-invasive carotid test
with )75% occlusion
Neurological dysfunction Severely affecting ambulation Patient has cerebrovascular disease,
disease or day-to-day functioning documented by any one of the
following: unresponsive coma )24 h,
CVA, RIND or TIA
Recent cardiac -90 days -30 days
infarct
AAA, abdominal aorta aneurism; CVA, cerebrovascular accident; RIND, reversible ischemic neurological deficit; TIA, transient ischemic attack.
Table 2
Observed and predicted mortality by risk tertiles
No. at No. of % observed No. of % predicted % difference P-value
risk observed deaths predicted deaths of difference
deaths deaths
EuroSCORE
1st 1448 4 0.28 13.1 0.91 69.5 0.048
2nd 1597 12 0.75 24.7 1.55 51.4 0.046
3rd 1522 28 1.84 69.2 4.55 59.5 -0.001
Total 4567 44 0.96 107.0 2.34 58.9 -0.001
Parsonnet
1st (0–2) 1230 7 0.57 32.0 2.60 78.1 -0.0001
2nd (3–5) 1911 12 0.63 63.8 3.34 81.2 -0.0001
3rd (6–28) 1426 25 1.75 135.5 9.50 81.6 -0.0001
Total 4567 44 0.96 202.3 4.43 78.3 -0.0001
OPR
1st (0–1) 2266 9 0.40 9.3 0.41 3.2 1
2nd (2–3) 1782 25 1.40 41.5 2.33 39.8 0.048
3rd (4–9) 519 10 1.93 24.8 4.48 59.7 0.015
Total 4567 44 0.96 75.8 1.66 41.9 0.005
The AUC for the model was 0.752 (95% CI, 0.739–0.764),
and the mean AUC from the bootstrap re-sampling was
0.752 (95% CI, 0.747–0.758). These results suggest that the
risk model has acceptable discriminatory ability, internal
validity and stability and, hence, may be used to stratify
patients into risk groups for surgical management.
4. Discussion
Currently used risk-score systems have been developed
for quite sometime now and do not reflect improved
surgical techniques and postoperative patient management
advances which occurred in recent times. In addition, they
are usually applied without validation to patient popula-
tions different from those from which they were derived.
We had been aware of the relative incapacity of these risk-
score systems to accurately predict in-hospital mortality in
our patients subjected to CABG, which was persistently
overestimated.
To confirm this assumption, one of the objectives of the
present study was to adequately assess the validity of three
risk-adjusted predictive models – the EuroSCORE, the Par-
sonnet score and the OPR score – in predicting in-hospital
mortality in our population of coronary surgery patients.
To this aim, each of these models’ performance was
assessed with regard to discrimination and calibration. We
were able to confirm that the three risk-score systems
analyzed do not accurately predict outcomes in this group
of 4567 patients. They all significantly overestimated total
observed outcomes. Additionally, the exploration of risk
tertiles showed that all models significantly overestimated
mortality at each risk group, except for the OPR in the first
tertile. These results suggest the use of these scoring
systems for patient advice of risk prediction is not appro-
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Table 3
Risk model for in-hospital mortality
Variable Coefficients P-value Bootstrap Odds 95% CI (OR)
frequency, % ratio
Age (per one year increase) 0.052 0.006 97.8 1.054 1.015 1.094
Peripheral vascular disease 1.575 -0.001 71.2 4.831 2.590 9.010
LV dysfunction (EF-40%) 0.688 0.055 67.3 1.989 0.985 4.016
Non-elective surgery 1.201 0.002 61.3 3.323 1.556 7.097
Reoperation 1.617 0.009 53.5 5.040 1.486 17.090
Intercept y8.601 -0.001
Model: x w5 d.f.xs48.45, P-0.001.2
Fig. 1. Observed vs. expected mortality by decile of predicted risk.
priate in our population. However, the discriminatory abil-
ity of the EuroSCORE was good, with an AUC of 0.754,
suggesting that this risk-score may be used in our popula-
tion to stratify patients into risk groups for treatment
management.
Consequent to these findings, confirming our previous
assumptions, the main goal of this study was the develop-
ment of our own risk model for our patient population
undergoing CABG surgery, which could be used as an instru-
ment to provide information to clinicians and patients
about the risk of surgical mortality.
The risk factors included in our risk model were: age,
reoperation, peripheral vascular disease, left ventricular
dysfunction and non-elective surgery. The main risk factors
observed here remain consistent with the findings in most
previously published risk models for CABG mortality w10x.
On the other hand, and in contrast to what has been found
in other studies w12–14x, population variables such as
female sex, renal dysfunction and diabetes mellitus, did
not emerge as independent risk factors in this study. The
prediction model demonstrated acceptable discriminatory
ability and accurately predicts in-hospital mortality, both
on average and across the ranges of patient deciles of risk.
The end-point of the study was in-hospital mortality.
Although it represents one of the most widely reported
metrics to assess death after CABG, it may be a too short
interval for the evaluation of early risk. Nevertheless, and
in the context of the present study, we believe that the
more important issue, other than the specific measure
used, is the ability to measure and validate it conveniently
and accurately. The mortality risk predicted by the Euro-
SCORE was only 2.34%. This result places this patient cohort
in a low risk profile, which means that any inference must
be reduced to the center where it was developed, possibly
limiting the applicability to others.
Although there is no consensus on sample size, as a rule
of thumb in studies deriving multivariable prognostic mod-
els, ten or more events per variable are usually required
in order to get a robust estimation of the coefficients. The
ratio of events to risk factors included in our local model
was approximately 9–1 (44 events; 5 variables), therefore,
the data of the multivariate analysis should be interpreted
with caution.
In our database, some of the variables selected for anal-
ysis (ejection fraction, hematocrit, cardiothoracic ratio)
were codified as categorical instead of continuous variables
and, consequently, this fact constitutes one limitation to
the process of correct model building.
5. Conclusion
We believe that scores described in published studies are
often not correct because the scoring system had not been
appropriately validated for the respective populations. We
developed a risk-prediction model that can be used as an
instrument to provide information to clinicians and patients
about the risk of in-hospital mortality in our patient popu-
lation awaiting CABG surgery. Naturally, it is for our own
use and is not intended for use in other patient populations.
Appendix A
Risk factors included in the data-base used for the
calculations
Age, gender, body mass index (BMI), diabetes (noyyes;
history of diabetes treated with oral agents or insulin),
hypertension (noyyes; blood pressure exceeding 140y
90 mmHg, or a history of high blood pressure, or the need
of antihypertensive medications), renal failure (none or
functioning transplantycreatinine )2.0 mgydl and no dial-
ysis dependency), recent smoking (noyup to less than four
weeks of surgery), anemia (noyhematocritF34%), cardio-
megaly (noycardiothoracic ratio )0.50 on a chest X-ray-
film), chronic pulmonary disease (noyyes), peripheral
vascular disease (noyyes), cerebrovascular disease (noy
yes), recent myocardial infarction (noyyes), unstable angi-
na (noyyes), angina CCS class III or IV (noyyes), left main
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disease (noyyes), three vessel disease (noyyes), reopera-
tion (noyyes), left ventricular dysfunction (noyejection
fraction-40%), non-elective surgery (noypatient requires
urgent or emergent surgery), intra-aortic balloon pump
(noypreoperative intra-aortic balloon pump for hemodyn-
amic reasons).
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Conference discussion
Dr. P. Kolh (Liege, Belgium): That is a very nice study. Recently a colleague
from Sweden published a very comprehensive study in the European Heart
Journal (Nilsson J. et al. 2006;27:867–874) comparing 19 models that would
predict risk in cardiac surgery, and the best one for coronary artery surgery
was the EuroSCORE, followed by the Cleveland Clinic and the New York
State scores. The Parsonnet score did not perform well, and it could be
expected because the Parsonnet score is relatively old now, about 20 years
old. I have two comments and questions.
The first one is a question. Do you plan to validate your model using
another population? Because now you have developed a model and you have
validated your model with your own population, but you would need to see
whether it works in other population settings.
The second one is, if I remember correctly, in one of your slides you are
using in-hospital mortality while most models use 30-day mortality. It is an
important difference, because if you decrease the length of hospital stay,
for a total number of patients who died within 30-day, more patients would
die in the interval between hospital discharge and the 30-day endpoint. So
I would appreciate if you could comment on that also.
Dr. Antunes: I’ll start with that question first. We just wanted this study
as an exercise of assessing our own performance and because most of our
patients go out to their cardiologists, it was difficult for this analysis to try
and get all the follow-up data on the 4,500 patients. That is why we used
that. We recognize that it will underestimate the mortality, but the curves
are pretty parallel. And if you see our initial comparison, it also shows that
the EuroSCORE, although being the best performer, was a little bit away
from our own observed and expected rates of mortality.
To answer your first question, as we developed the model we observed
that as our experience progressed, the curves started to diverge again. So
we need to recalibrate these models time and time again. And that is the
problem with the currently used models is that they were established some
10, 15 or 20 years ago and they were not recalibrated for current needs.
Dr. P. Kappetein (Rotterdam, The Netherlands): Great presentation and I
fully agree with the previous discussant that the models that are currently
available are not so valid anymore. I wonder if everybody shouldn’t use a
model they develop in their own institution. There are now many papers in
literature that show that EuroSCORE gives a higher predicted than observed
mortality and many authors present their own scoring system. So my question
is, do you think that we now should use the Coimbra score instead of the
EuroSCORE or that we should develop a score for our own institution?
Dr. Antunes: No, the message I want to bring is that these commonly
accepted risk scores do not always predict accurately your own internal
results, specific of your local institution. This model we developed is for
internal use only, so that we keep a record of our own performance. We do
not intend to suggest to anybody to use the score, because obviously the
populations are different and the methodologies are different. We cannot
compare our own performance, and we need to keep a track on that, if we
constantly use a model that shifts far away from our observed circumstances.
That is all.
Dr. K. Hekmat (Ulm, Germany): Congratulations on your score because
there are only five variables and I think that is very nice for all the residents
who have to do this scoring. I have just problems with two of the variables.
One is peripheral vascular disease. You didn’t define it, because you can
have a different extent. And the other one is also the ejection fraction,
because you don’t have it on all the patients, and the same is also true for
the peripheral vascular disease. So if you don’t have data on these two
variables, I think you can get problems with the score.
Dr. Antunes: No, we do have that data, and the presentation is limited to
five minutes. The paper, if it is published, and I hope so, will have the
definitions of all those 22 variables that we have here. But, just for your
own information, LV dysfunction was defined as less than 40% ejection
fraction, and peripheral vascular disease was diffuse disease in more than
one territory.
Dr. Hekmat: And you have data on all the patients, 100%?
Dr. Antunes: You can’t have complete data on 4,500 patients, but I would
say more than 95%, because this is a prospectively collected database. I
can’t guarantee that all the surgeons have put in all the variables, but
pretty close to that.
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